University Of Tasmania
140994 - A drug-tunable Flt23k gene therapy - Final author version.pdf (704.55 kB)
Download file

A drug-tunable Flt23k gene therapy for controlled intervention in retinal neovascularization

Download (704.55 kB)
journal contribution
posted on 2023-05-20, 17:59 authored by Chen, J, Fan-Li Lin, Jacqueline LeungJacqueline Leung, Tu, L, Wang, J-H, Chuang, Y-F, Li, F, Shen, H-H, Dusting, GJ, Wong, VHY, Lisowski, L, Alexander HewittAlexander Hewitt, Bui, BV, Zhong, J, Guei-Sheung LiuGuei-Sheung Liu
Gene therapies that chronically suppress vascular endothelial growth factor (VEGF) represent a new approach for managing retinal vascular leakage and neovascularization. However, constitutive suppression of VEGF in the eye may have deleterious side effects. Here, we developed a novel strategy to introduce Flt23k, a decoy receptor that binds intracellular VEGF, fused to the destabilizing domain (DD) of Escherichia coli dihydrofolate reductase (DHFR) into the retina. The expressed DHFR(DD)-Flt23k fusion protein is degraded unless "switched on" by administering a stabilizer; in this case, the antibiotic trimethoprim (TMP). Cells transfected with the DHFR(DD)-Flt23k construct expressed the fusion protein at levels correlated with the TMP dose. Stabilization of the DHFR(DD)-Flt23k fusion protein by TMP was able to inhibit intracellular VEGF in hypoxic cells. Intravitreal injection of self-complementary adeno-associated viral vector (scAAV)-DHFR(DD)-Flt23k and subsequent administration of TMP resulted in tunable suppression of ischemia-induced retinal neovascularization in a rat model of oxygen-induced retinopathy (OIR). Hence, our study suggests a promising novel approach for the treatment of retinal neovascularization. Schematic diagram of the tunable system utilizing the DHFR(DD)-Flt23k approach to reduce VEGF secretion. a The schematic shows normal VEGF secretion. b Without the ligand TMP, the DHFR(DD)-Flt23k protein is destabilized and degraded by the proteasome. c In the presence of the ligand TMP, DHFR(DD)-Flt23k is stabilized and sequestered in the ER, thereby conditionally inhibiting VEGF. Green lines indicate the intracellular and extracellular distributions of VEGF. Blue lines indicate proteasomal degradation of the DHFR(DD)-Flt23k protein. Orange lines indicate the uptake of cell-permeable TMP. TMP, trimethoprim; VEGF, vascular endothelial growth factor; ER, endoplasmic reticulum.


National Health & Medical Research Council


Publication title









Menzies Institute for Medical Research


Springer Netherlands

Place of publication


Rights statement

Copyright 2020 Springer Nature B.V.

Repository Status

  • Restricted

Socio-economic Objectives

Clinical health not elsewhere classified; Expanding knowledge in the environmental sciences